Stay updated on REGN 2810 vs Platinum Chemo in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the REGN 2810 vs Platinum Chemo in Metastatic NSCLC Clinical Trial page.

Latest updates to the REGN 2810 vs Platinum Chemo in Metastatic NSCLC Clinical Trial page
- Check4 days agoChange DetectedResults posted for the study, including Adverse Events and Outcome Measures (Results); a new revision (v3.6.2) was added, replacing the prior revision (v3.6.0).SummaryDifference0.7%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new recruitment status message 'No longer looking for participants' was added. The record's revision history shows a new version v3.6.0 and the earlier revision v3.5.5 has been removed.SummaryDifference0.3%

- Check25 days agoChange DetectedA new revision entry v3.5.5 is added and v3.5.4 is removed from the study record history, updating the page's revision metadata.SummaryDifference0.1%

- Check47 days agoChange DetectedThe record history adds a 2026-05-08 entry with a new revision (v3.5.4) and flags that Quality Control has not concluded, while adding sections for Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Document Section to the study record.SummaryDifference1%

- Check68 days agoChange DetectedThe record history indicates that results have been submitted for the study (transitioning from a state where no results were posted to one where results submission is recorded), alongside an updated site/application revision label.SummaryDifference0.2%

- Check75 days agoChange DetectedRevision history now shows an added v3.5.2 and a removed v3.5.0.SummaryDifference0.1%

Stay in the know with updates to REGN 2810 vs Platinum Chemo in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN 2810 vs Platinum Chemo in Metastatic NSCLC Clinical Trial page.